BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 22435550)

  • 1. Regulation of NF-κB by deubiquitinases.
    Harhaj EW; Dixit VM
    Immunol Rev; 2012 Mar; 246(1):107-24. PubMed ID: 22435550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinases in the regulation of NF-κB signaling.
    Harhaj EW; Dixit VM
    Cell Res; 2011 Jan; 21(1):22-39. PubMed ID: 21119682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of NF-κB signaling by the A20 deubiquitinase.
    Shembade N; Harhaj EW
    Cell Mol Immunol; 2012 Mar; 9(2):123-30. PubMed ID: 22343828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear ubiquitination-mediated NF-κB regulation and its related disorders.
    Tokunaga F
    J Biochem; 2013 Oct; 154(4):313-23. PubMed ID: 23969028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
    Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
    Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
    Li P; Wang Y; Turner JH
    Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
    Sun SC
    Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linear ubiquitination in immunity.
    Shimizu Y; Taraborrelli L; Walczak H
    Immunol Rev; 2015 Jul; 266(1):190-207. PubMed ID: 26085216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The K48-K63 Branched Ubiquitin Chain Regulates NF-κB Signaling.
    Ohtake F; Saeki Y; Ishido S; Kanno J; Tanaka K
    Mol Cell; 2016 Oct; 64(2):251-266. PubMed ID: 27746020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating dynamic protein-protein interactions and ubiquitination in NF-κB signaling pathways.
    Shembade N; Harhaj EW
    Methods Mol Biol; 2015; 1280():283-95. PubMed ID: 25736755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
    Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
    Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
    Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
    Front Immunol; 2020; 11():1559. PubMed ID: 32849529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
    Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
    J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
    Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
    EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-associated domain-containing ubiquitin regulatory X (UBX) protein UBXN1 is a negative regulator of nuclear factor κB (NF-κB) signaling.
    Wang YB; Tan B; Mu R; Chang Y; Wu M; Tu HQ; Zhang YC; Guo SS; Qin XH; Li T; Li WH; Li AL; Zhang XM; Li HY
    J Biol Chem; 2015 Apr; 290(16):10395-405. PubMed ID: 25681446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.
    Lork M; Verhelst K; Beyaert R
    Cell Death Differ; 2017 Jul; 24(7):1172-1183. PubMed ID: 28362430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of the A20/ABIN-mediated inhibition of NF-κB signaling via modifying the ubiquitinated proteins in a basal chordate.
    Yuan S; Dong X; Tao X; Xu L; Ruan J; Peng J; Xu A
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6720-5. PubMed ID: 24753567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A20: central gatekeeper in inflammation and immunity.
    Coornaert B; Carpentier I; Beyaert R
    J Biol Chem; 2009 Mar; 284(13):8217-21. PubMed ID: 19008218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A20 suppresses vascular inflammation by recruiting proinflammatory signaling molecules to intracellular aggresomes.
    Enesa K; Moll HP; Luong L; Ferran C; Evans PC
    FASEB J; 2015 May; 29(5):1869-78. PubMed ID: 25667218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine 63 polyubiquitination in immunotherapy and in cancer-promoting inflammation.
    Martinez-Forero I; Rouzaut A; Palazon A; Dubrot J; Melero I
    Clin Cancer Res; 2009 Nov; 15(22):6751-7. PubMed ID: 19887490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.